Impedimed Selling And Marketing Expenses from 2010 to 2024

Stocks . Australia . 
Stock . Impedimed
IPD Stock   0.05  0  2.00%   
Impedimed Selling And Marketing Expenses yearly trend continues to be comparatively stable with very little volatility. Selling And Marketing Expenses is likely to outpace its year average in 2024. From the period from 2010 to 2024, Impedimed Selling And Marketing Expenses quarterly data regression had r-value of (0.11) and coefficient of variation of  41.46. View All Fundamentals
 
Selling And Marketing Expenses  
First Reported
2007-12-31
Previous Quarter
773 K
Current Value
524 K
Quarterly Volatility
1.3 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Impedimed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Impedimed's main balance sheet or income statement drivers, such as Interest Expense of 88.3 K, Selling General Administrative of 23.2 M or Total Revenue of 5.2 M, as well as many indicators such as . Impedimed financial statements analysis is a perfect complement when working with Impedimed Valuation or Volatility modules.
  
This module can also supplement various Impedimed Technical models . Check out the analysis of Impedimed Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Impedimed Stock Analysis

When running Impedimed's price analysis, check to measure Impedimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Impedimed is operating at the current time. Most of Impedimed's value examination focuses on studying past and present price action to predict the probability of Impedimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Impedimed's price. Additionally, you may evaluate how the addition of Impedimed to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY